Correlation Between Akoya Biosciences and AtriCure

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akoya Biosciences and AtriCure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akoya Biosciences and AtriCure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akoya Biosciences and AtriCure, you can compare the effects of market volatilities on Akoya Biosciences and AtriCure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akoya Biosciences with a short position of AtriCure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akoya Biosciences and AtriCure.

Diversification Opportunities for Akoya Biosciences and AtriCure

0.71
  Correlation Coefficient

Poor diversification

The 3 months correlation between Akoya and AtriCure is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Akoya Biosciences and AtriCure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AtriCure and Akoya Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akoya Biosciences are associated (or correlated) with AtriCure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AtriCure has no effect on the direction of Akoya Biosciences i.e., Akoya Biosciences and AtriCure go up and down completely randomly.

Pair Corralation between Akoya Biosciences and AtriCure

Given the investment horizon of 90 days Akoya Biosciences is expected to under-perform the AtriCure. In addition to that, Akoya Biosciences is 1.67 times more volatile than AtriCure. It trades about -0.01 of its total potential returns per unit of risk. AtriCure is currently generating about -0.01 per unit of volatility. If you would invest  4,813  in AtriCure on August 15, 2024 and sell it today you would lose (1,193) from holding AtriCure or give up 24.79% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Akoya Biosciences  vs.  AtriCure

 Performance 
       Timeline  
Akoya Biosciences 

Risk-Adjusted Performance

11 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Akoya Biosciences are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat uncertain basic indicators, Akoya Biosciences sustained solid returns over the last few months and may actually be approaching a breakup point.
AtriCure 

Risk-Adjusted Performance

18 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in AtriCure are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, AtriCure exhibited solid returns over the last few months and may actually be approaching a breakup point.

Akoya Biosciences and AtriCure Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akoya Biosciences and AtriCure

The main advantage of trading using opposite Akoya Biosciences and AtriCure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akoya Biosciences position performs unexpectedly, AtriCure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AtriCure will offset losses from the drop in AtriCure's long position.
The idea behind Akoya Biosciences and AtriCure pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Other Complementary Tools

Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Stocks Directory
Find actively traded stocks across global markets
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device